Trading status Status de
  • Prices realtime
    • Indizes
      • Germany 40
      • MID Germany 50
      • TEC Germany 30
      • USA 30
      • EUROPE 50
      • TEC USA 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 2309
  • 2310
  • 2311
  • …
  • ›
  • »

2026-08-07

Sun Life Q2 Profit Rises

2026-08-07

NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

2026-08-07

Should You Sell Federal Signal Stock After Its Board Chair Offloaded 13,720 Shares?

2026-08-07

Stock Market Today, Aug. 6: Trade Desk Plummets After Hours on Weak Q2 Results

2026-08-07

Should You Sell Cactus Stock After a Company Insider Offloaded 7,100 Shares?

2026-08-07

Goosehead Insurance Director Buys $100K oif Shares. What Does This Signal to Investors?

2026-08-07

Is Cactus Stock Still a Buy After a Board Member Shed 10,000 Shares?

2026-08-07

Chinese luxury brands rise from challengers to market shapers as global houses lose lustre

2026-08-07

E.W. Scripps reports Q2 results

2026-08-07

WELL Health Technologies Non-GAAP EPS of $0.04 misses by $0.02, revenue of $400.43M beats by $13.8M

2026-08-07

Grupo Aeroportuario Del Pacifico Announces Changes to Its Management Team

2026-08-06

Replimune gains accelerated approval of Tudriqev for cutaneous melanoma

  • «
  • ‹
  • …
  • 2309
  • 2310
  • 2311
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies